UCSF School of Medicine
The UCSF School of Medicine strives to advance human health through a fourfold mission of education, research, patient care and public service.
https://www.ucsf.edu/
https://www.ucsf.edu/
ASH 2022 Long-Term Outcomes of Patients With TDT Followed Up to 8 Years Post-Treatment With Betibeglogene Autotemcel Gene Therapy and Predictors of Successful Treatment Outcomes in Phase 3 Trials
By
ASH 2022 Conference Coverage
FEATURING
Mark Walters
By
ASH 2022 Conference Coverage
FEATURING
Mark Walters
Login to view comments.
Click here to Login
Oncology & Hematology